| Dr Susan Sosun Kwong, OD | |
|
12310 Ne 8th St Ste 101, Bellevue, WA 98005-3185 | |
| (425) 455-0001 | |
| (425) 462-7387 |
| Full Name | Dr Susan Sosun Kwong |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 19 Years |
| Location | 12310 Ne 8th St Ste 101, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134265218 | NPI | - | NPPES |
| OD00004010 | Other | WA | OPTOMETRY LICENSE NUMBER |
| OPT 12906T | Other | CA | OPTOMETRY LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 12906T (California) | Secondary |
| 152W00000X | Optometrist | OD00004010 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aeg Washington Professional Pc | 3476927997 | 13 |
News Archive
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012.
Pall Corporation today announced that it has completed the previously announced public offering of its $375 million aggregate principal amount of 5.00% Senior Notes due June 15, 2020.
A team of scientists of Ural Federal University headed by Prof. Vladimir Kublanov created a hardware-information system for brain disorders prophylaxis and treatment unrivaled both in Russia and throughout the world.
'Healthy' smokers experience changes in the gene expression of their lungs similar to that suffered by smokers who have developed Chronic Obstructive Pulmonary Disease (COPD). This is the conclusion of a new study, led by Catalan researchers, which confirms the crucial role that smoking plays in causing these alterations.
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
› Verified 6 days ago
| Provider Name | Eyecare Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518953058 PECOS PAC ID: 8729031570 Enrollment ID: O20050222000378 |
News Archive
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012.
Pall Corporation today announced that it has completed the previously announced public offering of its $375 million aggregate principal amount of 5.00% Senior Notes due June 15, 2020.
A team of scientists of Ural Federal University headed by Prof. Vladimir Kublanov created a hardware-information system for brain disorders prophylaxis and treatment unrivaled both in Russia and throughout the world.
'Healthy' smokers experience changes in the gene expression of their lungs similar to that suffered by smokers who have developed Chronic Obstructive Pulmonary Disease (COPD). This is the conclusion of a new study, led by Catalan researchers, which confirms the crucial role that smoking plays in causing these alterations.
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
› Verified 6 days ago
| Provider Name | Aeg Washington Professional Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1134835176 PECOS PAC ID: 3476927997 Enrollment ID: O20230324001321 |
News Archive
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012.
Pall Corporation today announced that it has completed the previously announced public offering of its $375 million aggregate principal amount of 5.00% Senior Notes due June 15, 2020.
A team of scientists of Ural Federal University headed by Prof. Vladimir Kublanov created a hardware-information system for brain disorders prophylaxis and treatment unrivaled both in Russia and throughout the world.
'Healthy' smokers experience changes in the gene expression of their lungs similar to that suffered by smokers who have developed Chronic Obstructive Pulmonary Disease (COPD). This is the conclusion of a new study, led by Catalan researchers, which confirms the crucial role that smoking plays in causing these alterations.
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan Sosun Kwong, OD 3926 S Lucile St, Seattle, WA 98118-2258 Ph: (206) 280-8781 | Dr Susan Sosun Kwong, OD 12310 Ne 8th St Ste 101, Bellevue, WA 98005-3185 Ph: (425) 455-0001 |
News Archive
Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2012.
Pall Corporation today announced that it has completed the previously announced public offering of its $375 million aggregate principal amount of 5.00% Senior Notes due June 15, 2020.
A team of scientists of Ural Federal University headed by Prof. Vladimir Kublanov created a hardware-information system for brain disorders prophylaxis and treatment unrivaled both in Russia and throughout the world.
'Healthy' smokers experience changes in the gene expression of their lungs similar to that suffered by smokers who have developed Chronic Obstructive Pulmonary Disease (COPD). This is the conclusion of a new study, led by Catalan researchers, which confirms the crucial role that smoking plays in causing these alterations.
Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.
› Verified 6 days ago
Aimee Liu, OD Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Britlynn Chan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 11120 Ne 33rd Pl, Bellevue, WA 98004 Phone: 206-426-2584 | |
Adl Vision Llc Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Thomas Xie, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1020 108th Ave Ne Apt 1401, Bellevue, WA 98004 Phone: 347-687-0712 | |
Dr. Grant Edward Lindberg, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Joanna Stedman Haws, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Dr. Theodore Stephen Kadet, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 14030 Ne 24th St, Suite 101, Bellevue, WA 98007 Phone: 425-462-7800 Fax: 425-455-3019 |